Glycans in Drug Design


Glycans are components of many bio-therapeutic agents, ranging from natural products to molecules based on rational design to recombinant glycoproteins. The glycan components of these agents can be important determinants of their biological activity and therapeutic efficacy. Biochemistry and Glycobiology involves a multidisciplinary study of carbohydrate-binding proteins (lectins), glycolipids  and some other plant proteins that are capable of interacting with endogenous or foreign (macro) molecules.



 


    Related Conference of Glycans in Drug Design

    September 08-09, 2025

    23rd International Conference on Structural Biology

    Frankfurt, Germany
    September 29-30, 2025

    21st World Congress on Structural Biology

    Aix-en-Provence, France
    May 04-05, 2026

    7th International Conference on Drug Chemistry

    Paris, France

    Glycans in Drug Design Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in